Panic attacks are caused when patients feel with sudden surge of overwhelming anxiety and fear.
This report contains market size and forecasts of Panic Attack Treatment in Global, including the following market information:
Global Panic Attack Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Panic Attack Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Selective Serotonin Reuptake Inhibitor(SSRI) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Panic Attack Treatment include GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, Actavis Generics, Noven Pharmaceuticals, Inc., Recordati Rare Diseases(Recordati), Shionogi & Co., Ltd., Abbott Laboratories, Sumitomo Dainippon Pharma and Pfizer,Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Panic Attack Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Panic Attack Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Panic Attack Treatment Market Segment Percentages, by Type, 2021 (%)
Selective Serotonin Reuptake Inhibitor(SSRI)
Serotonin Norepinephrine Reuptake Inhibitor(SNRI)
Benzodiazepines(BZD)
Global Panic Attack Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Panic Attack Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Mental Healthcare Centers
Others
Global Panic Attack Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Panic Attack Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Panic Attack Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Panic Attack Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd
Actavis Generics
Noven Pharmaceuticals, Inc.
Recordati Rare Diseases(Recordati)
Shionogi & Co., Ltd.
Abbott Laboratories
Sumitomo Dainippon Pharma
Pfizer,Inc.
Bristol Myers Squibb(BMS)
Baxter International Inc.
Eli Lilly and Company